The experience of financial toxicity among advanced melanoma patients treated with immunotherapy Journal Article
| Authors: | Thom, B.; Mamoor, M.; Lavery, J. A.; Baxi, S. S.; Khan, N.; Rogak, L. J.; Sidlow, R.; Korenstein, D. |
| Article Title: | The experience of financial toxicity among advanced melanoma patients treated with immunotherapy |
| Abstract: | Purpose To measure financial toxicity and explore its association with quality of life (QOL) in an emerging population of survivors: advanced melanoma patients treated with immunotherapy. Design Cross-sectional survey and medical record review. Sample 106 survivors (39% response). Median time since start of immunotherapy was 36.4 months (range: 14.2–133.9). Methods The Comprehensive Score for Financial Toxicity measured financial toxicity, and the EORTC-QLQ30 assessed QOL and functioning across five domains. Data were collected online, by phone, or in clinic. Findings: Younger patients (<65 years) reported higher financial toxicity (p <.001) than older patients. Controlling for age, financial toxicity was correlated with QOL (p <.001), financial difficulties (p <.001), and EORTC-QLQ30 functioning subscales. Conclusions Given the demonstrated association between financial toxicity and QOL, our study highlights the importance of addressing financial toxicity, particularly among patients receiving high-cost treatments. Implications for Psychosocial Providers: Providers should educate patients and their caregivers about cost-management techniques, link them with available resources, and provide psychosocial counseling to alleviate related distress. © 2020 Taylor & Francis Group, LLC. |
| Keywords: | melanoma; quality of life; immunotherapy; financial toxicity |
| Journal Title: | Journal of Psychosocial Oncology |
| Volume: | 39 |
| Issue: | 2 |
| ISSN: | 0734-7332 |
| Publisher: | Taylor & Francis Group |
| Date Published: | 2021-01-01 |
| Start Page: | 285 |
| End Page: | 293 |
| Language: | English |
| DOI: | 10.1080/07347332.2020.1836547 |
| PUBMED: | 33103948 |
| PROVIDER: | scopus |
| PMCID: | PMC8437327 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 1 April 2021 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work